Pricing
  1. JP-listed companies
  3. Financials
  4. Effective tax rate (%)

(4586)

Market cap
¥6.6B
P/E ratio
Medrex develops new pharmaceuticals using proprietary skin-patch delivery technology that improves drug effectiveness and reduces side effects.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Dec 31, 2025-1.3+146.99%
Dec 31, 2024-0.5+75.75%
Dec 31, 2023-0.3+83.26%
Dec 31, 2022-0.2+30.66%
Dec 31, 2021-0.1-81.96%
Dec 31, 2020-0.7+134.43%
Dec 31, 2019-0.3+56.30%
Dec 31, 2018-0.2-56.44%
Dec 31, 2017-0.4+28.03%
Dec 31, 2016-0.3-21.67%
Dec 31, 2015-0.4+0.01%
Dec 31, 2014-0.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat